1. Immune checkpoint blockade: Releasing the brake towards hematological malignancies
   Yi Xia et al, 2016, Blood Reviews CrossRef
2. Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
   Xi Wang et al, 2021, Cancers CrossRef
3. Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine
   Nan Mu et al, 2014, BMB Reports CrossRef
4. Synergistic tumoricidal effect of combined hPD-L1 vaccine and HER2 gene vaccine
   Wangqian Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
5. What happens to regulatory T cells in multiple myeloma
   Huixian Chen et al, 2023, Cell Death Discovery CrossRef
6. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma
   Nan Jiang et al, 2023, npj Vaccines CrossRef
7. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
   Güllü Görgün et al, 2015, Clinical Cancer Research CrossRef
8. Vaccination of multiple myeloma: Current strategies and future prospects
   Alessandro Allegra et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
9. Reelin depletion alleviates multiple myeloma bone disease by promoting osteogenesis and inhibiting osteolysis
   Aixia Dou et al, 2021, Cell Death Discovery CrossRef
10. Co-immunizing with PD-L1 induces CD8+ DCs-mediated anti-tumor immunity in multiple myeloma
    Shuli Guo et al, 2020, International Immunopharmacology CrossRef